Similar Papers

Paper Title
Journal
Date
Author
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Adriaan J Van Der Meer ... Harry L.A Janssen
Journal of Hepatology | VOL. 60
Adriaan J Van Der Meer, et. al.Adriaan J Van Der Meer ... Harry L.A Janssen
20 Aug 2013
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
Manuel Romero-Gómez ... Jesús Castillo
Gastroenterology | VOL. 128
Manuel Romero-Gómez, et. al.Manuel Romero-Gómez ... Jesús Castillo
01 Mar 2005
Are viral or host factors predictive of response to interferon–ribavirin in transplant patients with hepatitis C?
Bruno Roche ... Didier Samuel
Journal of Hepatology | VOL. 52
Bruno Roche, et. al.Bruno Roche ... Didier Samuel
18 Feb 2010
Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified?
Robert J Fontana
Gastroenterology | VOL. 130
Robert J FontanaRobert J Fontana
01 Apr 2006
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancer.
Taek Chung ... Young Nyun Park
Journal of hepatology | VOL. -
Taek Chung, et. al.Taek Chung ... Young Nyun Park
18 Jan 2025
Modeling the Health and Economic Impact of Pharmacologic Therapies for MASLD in the United States.
Carolyn Wallace ... Arun J Sanyal
Journal of hepatology | VOL. -
Carolyn Wallace, et. al.Carolyn Wallace ... Arun J Sanyal
18 Jan 2025
On the need for an adult-to-adult liver graft split policy-An appraisal.
Xavier Muller ... Jean-Yves Mabrut
Journal of hepatology | VOL. -
Xavier Muller, et. al.Xavier Muller ... Jean-Yves Mabrut
18 Jan 2025
Reading through circular RNAs in MASLD: new diagnostic and therapeutic opportunities may come around.
Maite G Fernandez-Barrena ... Matias A Avila
Journal of hepatology | VOL. -
Maite G Fernandez-Barrena, et. al.Maite G Fernandez-Barrena ... Matias A Avila
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.